Neuroone Medical Technologies (NMTC) EBT Margin (2010 - 2026)
Neuroone Medical Technologies (NMTC) posted EBT Margin of 127.92% for Q1 2026, down 157.35% on a QoQ basis from 49.71% in Q4 2025, and up 3583.0% year-over-year from 3.47% in Q1 2025.
Neuroone Medical Technologies (NMTC) EBT Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies' EBT Margin history runs 13 years deep, the most recent figure standing at 127.92% for Q1 2026.
- Quarterly EBT Margin rose 3583.0% year-over-year to 127.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 75.5% (up 3916.0% YoY) and the FY2025 annual result came in at 39.63%, up 31711.0% from the prior year.
- EBT Margin was 127.92% for Q1 2026 at Neuroone Medical Technologies, down from 49.71% in the prior quarter.
- Across five years, EBT Margin topped out at 54.53% in Q4 2024 and bottomed at 8610.96% in Q2 2022.
- A 5-year average of 1456.4% and a median of 342.14% in 2023 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 2169548 bps in 2022, while the deepest fall reached 124961 bps in 2022.
- Neuroone Medical Technologies' EBT Margin stood at 1512.29% in 2022, then jumped by 77 bps to 342.14% in 2023, then soared by 116 bps to 54.53% in 2024, then plunged by 191 bps to 49.71% in 2025, then plunged by 157 bps to 127.92% in 2026.
- Business Quant data shows NMTC's EBT Margin at 127.92% in Q1 2026, 49.71% in Q4 2025, and 59.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | -127.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.92% |
| Dec 31, 2025 | -49.71% |
| Sep 30, 2025 | -59.08% |
| Jun 30, 2025 | -88.49% |
| Mar 31, 2025 | -163.76% |
| Dec 31, 2024 | 54.53% |
| Sep 30, 2024 | -1,230.55% |
| Jun 30, 2024 | -335.14% |
| Mar 31, 2024 | -207.30% |
| Dec 31, 2023 | -342.14% |
| Sep 30, 2023 | -422.65% |
| Jun 30, 2023 | -550.68% |
| Mar 31, 2023 | -755.69% |
| Dec 31, 2022 | -1,512.29% |
| Sep 30, 2022 | -1,997.94% |
| Jun 30, 2022 | -8,610.96% |
| Mar 31, 2022 | -8,359.03% |
| Dec 31, 2021 | -8,318.94% |
| Sep 30, 2021 | -23,693.42% |
| Jun 30, 2021 | -7,361.36% |